535 related articles for article (PubMed ID: 10945569)
1. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
2. Kappa light chain myeloma with initial cutaneous involvement.
Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
[No Abstract] [Full Text] [Related]
3. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
4. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
Jiwani S; Bornhost J; Alapat D
Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
[TBL] [Abstract][Full Text] [Related]
5. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell leukaemia mimicking acute monocytic leukaemia in the course of multiple myeloma.
Eclache V; Lusina D; Lejeune F; Casassus P; Smadja N; Lortholary P
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):419-22. PubMed ID: 8414961
[TBL] [Abstract][Full Text] [Related]
7. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell leukemia with pleomorphic plasma cells--a case report.
John S; Feroze M; Supriya NK; Aisabi KA
Indian J Pathol Microbiol; 2006 Jul; 49(3):438-9. PubMed ID: 17001915
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
Nozza A; Siracusano L; Armando S
Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
[TBL] [Abstract][Full Text] [Related]
13. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract][Full Text] [Related]
14. Pseudo-Gaucher cells in multiple myeloma.
Shenjere P; Roy A; Eyden B; Banerjee SS
Int J Surg Pathol; 2008 Apr; 16(2):176-9. PubMed ID: 18417675
[TBL] [Abstract][Full Text] [Related]
15. Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.
Méndez CE; Hwang BJ; Destian S; Mazumder A; Jagannath S; Vesole DH
Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):220-3. PubMed ID: 20511169
[TBL] [Abstract][Full Text] [Related]
16. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia].
Fujii H; Yashige H; Taniwaki M; Urata Y; Kuzuyama Y; Kitagawa Y; Horishi M; Suyama Y; Miyoshi M
Gan No Rinsho; 1990 Apr; 36(5):645-50. PubMed ID: 2109137
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of multiple myeloma and related disorders including amyloidosis.
Kyle RA
Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881
[TBL] [Abstract][Full Text] [Related]
18. A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma.
Corso A; Arcaini L; Caberlon S; Zappasodi P; Mangiacavalli S; Lorenzi A; Rusconi C; Troletti D; Maiocchi MA; Pascutto C; Morra E; Lazzarino M
Haematologica; 2002 Oct; 87(10):1041-5. PubMed ID: 12368158
[TBL] [Abstract][Full Text] [Related]
19. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
[TBL] [Abstract][Full Text] [Related]
20. [IgM myeloma: a report of 2 cases].
Masanés F; Pedrol E; Bladé J; Casademont J; de la Sierra A; Martínez-Orozco F; Grau JM; Ingelmo M
Med Clin (Barc); 1991 May; 96(20):777-9. PubMed ID: 1908542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
